Powell Andrew Kenneth William

SVP, General Counsel at IMCLONE SYSTEMS INC · on record since Nov 26, 2008
EVP, General Counsel at CORNERSTONE THERAPEUTICS INC · on record since Nov 3, 2009
Director at Aclaris Therapeutics, Inc. · on record since Jan 26, 2017
EVP, GC & Secretary at INTERMUNE INC · on record since Jun 11, 2014
SVP, General Counsel & Crp Sec at MEDIVATION, INC. · on record since May 29, 2015
Director at LIFECORE BIOMEDICAL, INC. \DE\ · on record since Oct 22, 2018
Director at Synthorx, Inc. · on record since Dec 21, 2018
VP, G. Counsel and Corp. Sec. at COLLAGENEX PHARMACEUTICALS INC · on record since Mar 17, 2005
Director at ARS Pharmaceuticals, Inc. · on record since Dec 7, 2020

Insider trading activity of Powell Andrew Kenneth William

Transactions on record: 114; since Sep 24, 2004

Open-market buys: 13; $52.9K

Open-market sells: 8; $837.6K

Companies traded: 9; last filing Jun 4, 2024

Figures computed from official regulatory filings — .

Companies where Powell Andrew Kenneth William has traded

Aclaris Therapeutics, Inc.28 tx · $27.5K · Jun 4, 2024
ARS Pharmaceuticals, Inc.3 tx · Jun 13, 2022
LIFECORE BIOMEDICAL, INC. \DE\16 tx · $451.1K · Jun 7, 2022
Synthorx, Inc.4 tx · $1.8M · Jan 24, 2020
MEDIVATION, INC.11 tx · $155.8K · Sep 30, 2016
INTERMUNE INC22 tx · $1.3M · Oct 1, 2014
10 tx · $104.2K · Aug 30, 2013
5 tx · Nov 26, 2008
15 tx · $22.2K · Nov 30, 2007

Track record of Powell Andrew Kenneth William

Statistical track record

Free account

Open-market buys: 13

Last buy: Mar 4, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Powell Andrew Kenneth William

Co-insiders of Powell Andrew Kenneth William

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Aclaris Therapeutics, Inc.Listing on record	Jun 4, 2024	Exercise	4,660	—	n/a (No price was disclosed in the filing)		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 4, 2024	ExerciseD (derivative)	-4,660	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Mar 5, 2024	Buy	8,500	1.23 USD	$10.5K	conv 71Unusual sizeFirst in 12mo	SEC
Aclaris Therapeutics, Inc.Listing on record	Mar 5, 2024	Buy	6,000	1.25 USD	$7.5K	conv 38	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 5, 2023	AwardD (derivative)	15,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 5, 2023	Exercise	4,507	—	n/a (No price was disclosed in the filing)		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 5, 2023	ExerciseD (derivative)	-4,507	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 5, 2023	AwardD (derivative)	4,660	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jan 20, 2023	Gift	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARS Pharmaceuticals, Inc.Listing on record	Jun 13, 2022	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 7, 2022	Award	7,059	9.50 USD	$67.1K	Unusual size	SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 7, 2022	ExerciseD (derivative)	-7,059	9.50 USD	$67.1K		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	ExerciseD (derivative)	-3,356	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	AwardD (derivative)	4,507	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	AwardD (derivative)	15,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	Gift	-709	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	Exercise	3,356	—	n/a (No price was disclosed in the filing)		SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 2, 2022	AwardD (derivative)	9,474	—	n/a (No price was disclosed in the filing)		SEC
Aclaris Therapeutics, Inc.Listing on record	Dec 3, 2021	Gift	-5,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARS Pharmaceuticals, Inc.Listing on record	Sep 21, 2021	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 8, 2021	AwardD (derivative)	7,059	—	n/a (No price was disclosed in the filing)		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 4, 2021	AwardD (derivative)	3,356	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 4, 2021	AwardD (derivative)	12,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 3, 2021	ExerciseD (derivative)	-8,303	11.64 USD	$96.6K	Unusual size	SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 3, 2021	Award	8,303	11.64 USD	$96.6K	Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Aclaris Therapeutics, Inc.Listing on record	Jun 4, 2024	Exercise	4,660	—	n/a (No price was disclosed in the filing)		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 4, 2024	ExerciseD (derivative)	-4,660	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Mar 5, 2024	Buy	8,500	1.23 USD	$10.5K	conv 71Unusual sizeFirst in 12mo	SEC
Aclaris Therapeutics, Inc.Listing on record	Mar 5, 2024	Buy	6,000	1.25 USD	$7.5K	conv 38	SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 5, 2023	AwardD (derivative)	15,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 5, 2023	Exercise	4,507	—	n/a (No price was disclosed in the filing)		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 5, 2023	ExerciseD (derivative)	-4,507	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 5, 2023	AwardD (derivative)	4,660	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jan 20, 2023	Gift	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARS Pharmaceuticals, Inc.Listing on record	Jun 13, 2022	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 7, 2022	Award	7,059	9.50 USD	$67.1K	Unusual size	SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 7, 2022	ExerciseD (derivative)	-7,059	9.50 USD	$67.1K		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	ExerciseD (derivative)	-3,356	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	AwardD (derivative)	4,507	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	AwardD (derivative)	15,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	Gift	-709	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 6, 2022	Exercise	3,356	—	n/a (No price was disclosed in the filing)		SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 2, 2022	AwardD (derivative)	9,474	—	n/a (No price was disclosed in the filing)		SEC
Aclaris Therapeutics, Inc.Listing on record	Dec 3, 2021	Gift	-5,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARS Pharmaceuticals, Inc.Listing on record	Sep 21, 2021	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 8, 2021	AwardD (derivative)	7,059	—	n/a (No price was disclosed in the filing)		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 4, 2021	AwardD (derivative)	3,356	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aclaris Therapeutics, Inc.Listing on record	Jun 4, 2021	AwardD (derivative)	12,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 3, 2021	ExerciseD (derivative)	-8,303	11.64 USD	$96.6K	Unusual size	SEC
LIFECORE BIOMEDICAL, INC. \DE\Listing on record	Jun 3, 2021	Award	8,303	11.64 USD	$96.6K	Unusual size	SEC